PierianDx Names Chris Callahan as Chief Commercial Officer to Drive Expansion of its Genomics Technology Platform for Clinical Labs

April 11, 2018
PierianDx named Chris Callahan as the new Chief Commercial Officer to accelerate adoption and expansion of the company’s enterprise informatics software platform, the Clinical Genomics WorkSpace (CGW). Chris will report to PierianDx CEO Rakesh
Read More

Cardiology Field Whole-heartedly Ready for Precision Medicine

April 10, 2018
Cardiovascular disease causes more deaths worldwide than any other disease. In 2015 alone, nearly 18 million people died from cardiovascular disease. And according to the World Health Organization, most cardiovascular disease can be prevented or
Read More

PierianDx Announces TriCore Reference Laboratories as the Newest Customer to its Partner Sharing Network

April 6, 2018
PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that TriCore Reference Laboratories will utilize the company’s Clinical Genomics WorkSpace™ (CGW) platform, the industry’s leading
Read More

All of Us Initiative: Highlighting the Need for Streamlined Genetic Analysis

April 6, 2018
Flashback: the Human Genome Project was launched in 1990 by Nobel Laureate, Dr. James Watson, at the NIH (National Institutes of Health). All told, sequencing the first human genome took 13 years and cost between $500 million and  $1 billion.
Read More

Inova Launches Predictive Phenotyping Study with NIH

April 5, 2018
In case you missed it, PierianDx customer, Inova, is launching a joint study with the National Institutes of Health (NIH) to “re-engineer” genomics. The study, called the Genomic Ascertainment Cohort (TGAC), launched in early March, will collect the
Read More

PierianDx to Unveil Blueprint for Bringing Next Generation Sequencing (NGS) Testing In-house at Executive War College

April 3, 2018
The drive to deliver precision medicine has galvanized many hospitals to in-source next generation sequencing (NGS) testing. Yet for hospital labs just getting started, the process can be overwhelming. They must build the business case for bringing
Read More

Identifying Disease Risks Associated with Premature Mortality: A Study from Human Longevity

March 28, 2018
Life gets better when we enter our "golden years" and retire, doesn’t it?  Not necessarily. Because we are living longer, we face the possibility of living with an age-related chronic disease. Cancer, diabetes, and heart disease top the list of
Read More

A Precision Medicine Approach for Rheumatoid Arthritis Patients

March 27, 2018
Rheumatoid arthritis affects 1.3 million Americans and approximately 1% of the worldwide population. Patients suffer from a host of symptoms, including debilitating joint pain and swelling, fatigue, and even depression. [1]  
Read More

PierianDx Customer, Moffitt Cancer Center, Launches Clinical NGS Assay, STAR

March 26, 2018
The Moffitt Morsani Molecular Laboratory, located within the Moffitt Cancer Center, announced today that it has launched a new clinical NGS assay, Solid Tumor Actionable Result, or STAR. STAR is based off of the Illumina TruSight Tumor 170 panel
Read More

PierianDx Showcases Germline Features in CGW at ACMG 2018

March 26, 2018
PierianDx will be highlighting germline features of its genomics technology platform the American College of Medical Genetics and Genomics (ACMG) annual meeting April 10-14 in Charlotte, North Carolina.
Read More

Subscribe Here!